Ekso Bionics Holdings, Inc. (EKSO) Coverage Initiated by Analysts at SunTrust Banks Inc.
Several other equities analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of Ekso Bionics Holdings from a hold rating to a sell rating in a research note on Tuesday, August 2nd. Rodman & Renshaw reaffirmed a buy rating on shares of Ekso Bionics Holdings in a research note on Sunday, July 31st. Finally, B. Riley began coverage on shares of Ekso Bionics Holdings in a research note on Wednesday, September 21st. They set a buy rating and a $8.00 price target for the company.
Ekso Bionics Holdings (NASDAQ:EKSO) traded down 6.2562% during trading on Thursday, reaching $5.6715. 320,484 shares of the company traded hands. The company’s 50-day moving average is $4.37 and its 200 day moving average is $5.40. Ekso Bionics Holdings has a 12 month low of $3.45 and a 12 month high of $10.08. The company’s market cap is $93.19 million.
Ekso Bionics Holdings (NASDAQ:EKSO) last announced its earnings results on Thursday, July 28th. The company reported ($0.61) EPS for the quarter, missing the consensus estimate of ($0.28) by $0.33. On average, analysts anticipate that Ekso Bionics Holdings will post ($1.74) earnings per share for the current year.
Receive News & Stock Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related stocks with our FREE daily email newsletter.